Literature DB >> 29865989

Association of sex and height with a lower ankle brachial index in the general population.

Ridhima Kapoor1, Colby Ayers2, Alexis Visotcky3, Peter Mason1, Jacquelyn Kulinski1.   

Abstract

The ankle-brachial index (ABI) is a predictor of cardiovascular events, mortality and functional status. Some studies have noted a higher prevalence of peripheral artery disease in females compared to males. Differences in height might account for these observed sex differences, but findings are conflicting. The 2003-2004 National Health and Nutrition Examination Survey (NHANES) cohort includes participants from 15 geographic locations, selected annually to represent the general population. Sample-weighted multivariable linear and logistic regression modeling was performed with ABI as the dependent variable and height and sex as primary exposure variables of interest. There were 3052 participants with ABI data (mean age 57 years, 51% female). The mean (±SE) ABI was 1.09 (±0.006) and 1.13 (±0.005) for females and males, respectively ( p < 0.0001). Shorter height was associated with a low ABI (OR 0.91 per 4 cm, 95% CI: 0.86-0.96; p=0.001). In a fully adjusted model, female sex was associated with a low ABI (OR 1.34, 95% CI: 1.04-1.72; p=0.025) independent of height and traditional cardiovascular disease (CVD) risk factors. Age, diabetes, tobacco use, known CVD, hypertension and race were associated with a low ABI (all p < 0.001). The ABI was 0.03 lower in females than in males in the general population and in a healthy cohort. Lower ABI values in healthy females do not appear to be due to occult vascular disease but rather a normal phenomenon with some contribution from height. Therefore, population sex-specific ABI thresholds should be utilized in the diagnosis of peripheral artery disease to account for these intrinsic differences.

Entities:  

Keywords:  ankle–brachial index (ABI); height; peripheral artery disease (PAD); sex differences

Mesh:

Year:  2018        PMID: 29865989      PMCID: PMC9552311          DOI: 10.1177/1358863X18774845

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   4.739


  41 in total

Review 1.  Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery.

Authors:  F L Moll; J T Powell; G Fraedrich; F Verzini; S Haulon; M Waltham; J A van Herwaarden; P J E Holt; J W van Keulen; B Rantner; F J V Schlösser; F Setacci; J-B Ricco
Journal:  Eur J Vasc Endovasc Surg       Date:  2011-01       Impact factor: 7.069

2.  Ankle-Brachial Index, Toe-Brachial Index, and Pulse Volume Recording in Healthy Young Adults.

Authors:  Yoshiko Watanabe; Hisao Masaki; Yasuhiro Yunoki; Atushi Tabuchi; Ichiro Morita; Satoshi Mohri; Kazuo Tanemoto
Journal:  Ann Vasc Dis       Date:  2015-08-12

3.  Lower extremity arterial disease assessed by ankle-brachial index in a middle-aged population of African Americans and whites: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Zhi-Jie Zheng; Wayne D Rosamond; Lloyd E Chambless; F Javier Nieto; Ralph W Barnes; Richard G Hutchinson; Herman A Tyroler; Gerardo Heiss
Journal:  Am J Prev Med       Date:  2005-12       Impact factor: 5.043

4.  Influence of sex on arterial hemodynamics and blood pressure. Role of body height.

Authors:  G M London; A P Guerin; B Pannier; S J Marchais; M Stimpel
Journal:  Hypertension       Date:  1995-09       Impact factor: 10.190

5.  Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

Authors:  Elizabeth Selvin; Thomas P Erlinger
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

Review 6.  Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis.

Authors:  F G R Fowkes; G D Murray; I Butcher; C L Heald; R J Lee; L E Chambless; A R Folsom; A T Hirsch; M Dramaix; G deBacker; J-C Wautrecht; M Kornitzer; A B Newman; M Cushman; K Sutton-Tyrrell; F G R Fowkes; A J Lee; J F Price; R B d'Agostino; J M Murabito; P E Norman; K Jamrozik; J D Curb; K H Masaki; B L Rodríguez; J M Dekker; L M Bouter; R J Heine; G Nijpels; C D A Stehouwer; L Ferrucci; M M McDermott; H E Stoffers; J D Hooi; J A Knottnerus; M Ogren; B Hedblad; J C Witteman; M M B Breteler; M G M Hunink; A Hofman; M H Criqui; R D Langer; A Fronek; W R Hiatt; R Hamman; H E Resnick; J Guralnik; M M McDermott
Journal:  JAMA       Date:  2008-07-09       Impact factor: 56.272

7.  The prevalence of peripheral arterial disease in a defined population.

Authors:  M H Criqui; A Fronek; E Barrett-Connor; M R Klauber; S Gabriel; D Goodman
Journal:  Circulation       Date:  1985-03       Impact factor: 29.690

8.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

9.  Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study.

Authors:  W R Hiatt; S Hoag; R F Hamman
Journal:  Circulation       Date:  1995-03-01       Impact factor: 29.690

10.  Women's involvement in clinical trials: historical perspective and future implications.

Authors:  Katherine A Liu; Natalie A Dipietro Mager
Journal:  Pharm Pract (Granada)       Date:  2016-03-15
View more
  2 in total

1.  Risk of peripheral artery disease according to race and sex: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Caitlin W Hicks; Ning Ding; Lucia Kwak; Shoshana H Ballew; Corey A Kalbaugh; Aaron R Folsom; Gerardo Heiss; Josef Coresh; James H Black; Elizabeth Selvin; Kunihiro Matsushita
Journal:  Atherosclerosis       Date:  2021-03-29       Impact factor: 5.162

2.  Epidemiology of Peripheral Artery Disease and Polyvascular Disease.

Authors:  Aaron W Aday; Kunihiro Matsushita
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.